Vice Chairman of Immunology at The Scripps Research Institute to Assist with ValloVax™ Clinical Development
Argyrios Theofilopoulos, MD, Joins Batu’s Scientific Advisory Board
Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, announced today the appointment of Argyrios Theofilopoulos, MD of The Scripps Research Institute to its scientific advisory board.
